David A Jenkins insider trades: Catheter Precision (VTAK) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 23, 2024 | VTAK | ↑ Buy | 19,056 | $0.51 | $10K | Direct | Jan 24, 2024 (1d) |
| Jan 19, 2024 | VTAK | ↑ Buy | 16,940 | $0.42 | $7K | Direct | Jan 22, 2024 (3d) |
| Jan 16, 2024 | VTAK | ↑ Buy | 16,263 | $0.39 | $6K | Direct | Jan 18, 2024 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About David A Jenkins's insider trades
David A Jenkins is Chairman of the Board and CEO at Catheter Precision (VTAK). Since Jan 16, 2024, David has reported 3 open-market purchases worth $23K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (6 filings), other transactions (3 filings), conversions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VTAK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.